Doctors warn that biotin supplements, popular among cancer patients seeking to restore hair lost during treatment, may do more harm than good. While biotin is often marketed for stronger hair and nails, experts highlight that there is little evidence supporting its effectiveness for cancer-related hair loss. More critically, biotin can interfere with crucial lab tests, potentially masking cancer recurrence and delaying important treatment decisions.

For many people undergoing cancer treatment, hair loss is one of the most distressing side effects. In their quest to regain their hair, patients often turn to biotin supplements, believing they are harmless. However, the reality is that biotin can distort key blood markers, leading to inaccurate results in tests that monitor cancers like prostate, thyroid, and breast cancer. This can result in false readings that may delay necessary medical interventions, putting patients at risk.

The evidence surrounding biotin’s impact is concerning but not definitive. The warnings come from experts at Ohio State University, who emphasize that the vitamin can interfere with blood tests. This advice stems from clinical observations rather than large-scale studies, meaning that while the risks are significant, further research is needed to fully understand the implications. For those who still wish to manage hair loss, dermatologists recommend safer alternatives, such as minoxidil, which is FDA-approved and available over the counter.

Source: sciencedaily.com